Some motive is working behind all these surprises. Agony of the issue here is the urgency under which things are happeining. I haven't seen any company working so fast to get some objective done.
Common 0.02% fatal ractions with ONLY IV multidose vials and that too only 2 deaths out of 25000 patients on list. Fresenius was about to conclude the Pilot trials and about to revoke the contract with AMGEN on 14th April 2013.......Something very very fishy...Orwin !